Výsledky vyhledávání - "Kristian Løvvik Juul‐Dam"

Publikováno v: British Journal of Haematology, 201(4), 757-765. Wiley-Blackwell
Karlsson, L, Cheuk, D, De Moerloose, B, Hasle, H, Jahnukainen, K, Juul-Dam, K L, Kaspers, G, Kovalova, Z, Lausen, B, Nyström, U N, Palle, J, Pronk, C J, Saks, K, Tierens, A, Zeller, B & Abrahamsson, J 2023, ' Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia ', British Journal of Haematology, vol. 201, no. 4, pp. 757-765 . https://doi.org/10.1111/bjh.18685
BRITISH JOURNAL OF HAEMATOLOGY
Karlsson, L, Cheuk, D, de Moerloose, B, Hasle, H, Jahnukainen, K, Juul-Dam, K L V, Kaspers, G, Kovalova, Z, Lausen, B, Nyström, U N, Palle, J, Pronk, C J, Saks, K, Tierens, A, Zeller, B & Abrahamsson, J 2023, ' Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia ', British Journal of Haematology, vol. 201, no. 4, pp. 757-765 . https://doi.org/10.1111/bjh.18685

A significant proportion of events in paediatric acute myeloid leukaemia (AML) are caused by resistant disease (RD). We investigated clinical and biological characteristics in 66 patients with RD from 1013 children with AML registered and treated acc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::687176c2713418c6fcf366f27a501db7
http://www.scopus.com/inward/record.url?scp=85147567145&partnerID=8YFLogxK

Zobrazit plný text záznamu

Vybrat výsledek číslo 4 4

Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse

Autor: Kristian Løvvik Juul-Dam, Henrik Hasle, Anne-Sofie Skou, Hans Beier Ommen

Publikováno v: Skou, A S, Juul-Dam, K L, Ommen, H B & Hasle, H 2021, ' Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse ', British Journal of Haematology, vol. 195, no. 3, pp. 310-327 . https://doi.org/10.1111/bjh.17449

Longitudinal molecular measurable residual disease (MRD) sampling after completion of therapy serves as a refined tool for identification of imminent relapse of acute myeloid leukaemia (AML) among patients in long-term haematological complete remissi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b325b8cd7460550dc6a9ff06dd3ffb54
https://doi.org/10.1111/bjh.17449

Zobrazit plný text záznamu

Vybrat výsledek číslo 5 5

Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia

Autor: Anni Aggerholm, Charlotte Guldborg Nyvold, Kristian Løvvik Juul-Dam, Svea Stratmann, Linda Holmfeldt, Birgitte Lausen, Hans Beier Ommen, Maria Hansen, Henrik Hasle, Anne-Sofie Skou

Publikováno v: Skou, A-S, Juul-Dam, K L, Hansen, M, Lausen, B, Stratmann, S, Holmfeldt, L, Aggerholm, A, Nyvold, C G, Ommen, H B & Hasle, H 2021, ' Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia ', The Journal of molecular diagnostics : JMD, vol. 23, no. 12, pp. 1787-1799 . https://doi.org/10.1016/j.jmoldx.2021.09.004
Skou, A S, Juul-Dam, K L, Hansen, M, Lausen, B, Stratmann, S, Holmfeldt, L, Aggerholm, A, Nyvold, C G, Ommen, H B & Hasle, H 2021, ' Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia ', Journal of Molecular Diagnostics, vol. 23, no. 12, pp. 1787-1799 . https://doi.org/10.1016/j.jmoldx.2021.09.004

Overexpressed genes may be useful for monitoring of measurable residual disease (MRD) in patients with childhood acute myeloid leukemia (AML) without a leukemia-specific target. The normal expression of five leukemia-associated genes (SPAG6, ST18, MS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e27b0e4d65dd29b053208fd282f37be6
https://pubmed.ncbi.nlm.nih.gov/34600138

Zobrazit plný text záznamu

Vybrat výsledek číslo 6 6

Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia

Autor: Barbara De Moerloose, Ninna Bager, Zhanna Kovalova, Berna Beverloo, Bernward Zeller, Eigil Kjeldsen, Julie Damgaard Sandahl, Birgitte Lausen, Olafur G. Jonsson, Eveline S. J. M. de Bont, Kirsi Jahnukainen, Henrik Hasle, Gertjan L. Kaspers, Kadri Saks, Josefine Palle, Ulrika Norén-Nyström, Kristian Løvvik Juul-Dam, Shau-Yin Ha, Jonas Abrahamsson

Publikováno v: British Journal of Haematology, 183(4), 618-628. Wiley-Blackwell Publishing Ltd
Bager, N, Juul-Dam, K L, Sandahl, J D, Abrahamsson, J, Beverloo, B, de Bont, E S J M, Ha, S-Y, Jahnukainen, K, Jónsson, Ó G, Kaspers, G L, Kovalova, Z, Lausen, B, de Moerloose, B, Noren-Nyström, U, Palle, J, Saks, K, Zeller, B, Kjeldsen, E & Hasle, H 2018, ' Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study ', British Journal of Haematology, vol. 183, no. 4, pp. 618-628 . https://doi.org/10.1111/bjh.15587
Bager, N, Juul-Dam, K L, Sandahl, J D, Abrahamsson, J, Beverloo, B, de Bont, E S J M, Ha, S-Y, Jahnukainen, K, Jónsson, Ó G, Kaspers, G L, Kovalova, Z, Lausen, B, De Moerloose, B, Noren-Nyström, U, Palle, J, Saks, K, Zeller, B, Kjeldsen, E & Hasle, H 2018, ' Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study ', British Journal of Haematology, vol. 183, no. 4, pp. 618-628 . https://doi.org/10.1111/bjh.15587
British Journal of Haematology, 183(4), 618-628. Wiley
British Journal of Haematology, 183(4), 618-628. Wiley-Blackwell

Data on occurrence, genetic characteristics and prognostic impact of complex and monosomal karyotype (CK/MK) in children with acute myeloid leukaemia (AML) are scarce. We studied CK and MK in a large unselected cohort of childhood AML patients diagno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a9e5916363a37e49a2149640bc18903
https://doi.org/10.1111/bjh.15587

Zobrazit plný text záznamu

Vybrat výsledek číslo 7 7

Patient-Tailored Measurable Residual Disease Monitoring in Peripheral Blood Using Deep Sequencing and Droplet Digital PCR for Early Detection of Relapse in Childhood Acute Myeloid Leukemia: A NOPHO-DBH Collaborative Study

Autor: Anni Aggerholm, Birgitte Lausen, Anna Rehammar, Jonas Abrahamsson, Edwin Sonneveld, Anne-Sofie Skou, Kirsi Jahnukainen, Anastasia Soboli, Kristian Løvvik Juul-Dam, Erik Delsing Malmberg, Erik Kristiansson, Bernward Zeller, Azadeh Anbarlou, Henrik Hasle, Hans Beier Ommen, Linda Fogelstrand

Publikováno v: Blood. 138:3457-3457

Close surveillance of measurable residual disease (MRD) following completion of therapy for acute myeloid leukemia (AML) enables early detection of relapse in time for pre-emptive treatment. Today this is available only for the fraction of patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3defe519051749c97bfd24260152c2c4
https://doi.org/10.1182/blood-2021-153411

Zobrazit plný text záznamu

Vybrat výsledek číslo 8 8

Akademický článek

Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol

Autor: Bernward Zeller, Nira Arad-Cohen, Daniel Cheuk, Barbara De Moerloose, Jose M. Fernandez Navarro, Henrik Hasle, Kirsi Jahnukainen, Kristian Lovvik Juul-Dam, Gertjan Kaspers, Zanna Kovalova, Olafur G. Jonsson, Birgitte Lausen, Monica Munthe-Kaas, Ulrika Noren Nystrom, Josefine Palle, Ramune Pasauliene, Cornelis J. Pronk, Kadri Saks, Anne Tierens, Jonas Abrahamsson

Publikováno v: Haematologica, Vol 999, Iss 1 (2024)

Hyperleukocytosis (HL) in pediatric acute myeloid leukemia (AML) is associated with severe complications and inferior outcome. We report results on HL patients included in the NOPHO-DBH AML 2012 study. We recommended immediate start of full dose chem

Externí odkaz: https://doaj.org/article/8e25aca1b1344749b1c04eda6ae6c96b

Zobrazit plný text záznamu

Vybrat výsledek číslo 9 9

Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia

Autor: Jonas Abrahamsson, Hans Beier Ommen, Helen Vålerhaugen, Kirsi Jahnukainen, Birgitte Lausen, Linda Fogelstrand, Sofie Johansson Alm, Christiane Walter, Bernward Zeller, Veli Kairisto, Nils von Neuhoff, Dirk Reinhardt, Henrik Hasle, Charlotte Guldborg Nyvold, Kristian Løvvik Juul-Dam

Publikováno v: Juul-Dam, K L, Ommen, H B, Nyvold, C G, Walter, C, Vålerhaugen, H, Kairisto, V, Abrahamsson, J, Alm, S J, Jahnukainen, K, Lausen, B, Reinhardt, D, Zeller, B, von Neuhoff, N, Fogelstrand, L & Hasle, H 2020, ' Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia ', British Journal of Haematology, vol. 190, no. 2, pp. 198-208 . https://doi.org/10.1111/bjh.16560
Løvvik Juul-Dam, K, Ommen, H B, Nyvold, C G, Walter, C, Vålerhaugen, H, Kairisto, V, Abrahamsson, J, Johansson Alm, S, Jahnukainen, K, Lausen, B, Reinhardt, D, Zeller, B, Von Neuhoff, N, Fogelstrand, L & Hasle, H 2018, ' Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia ', American Society of Hematology: 60th Annual Meeting (ASH), San Diego, USA, 29/11/2018-04/12/2018 . < https://ash.confex.com/ash/2018/webprogram/Paper119642.html >
Løvvik Juul-Dam, K, Ommen, H B, Nyvold, C G, Walter, C, Vålerhaugen, H, Kairisto, V, Abrahamsson, J, Johansson Alm, S, Jahnukainen, K, Lausen, B, Reinhardt, D, Zeller, B, Von Neuhoff, N, Fogelstrand, L & Hasle, H 2018, ' Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia ', Blood, vol. 132, no. Suppl. 1 . https://doi.org/10.1182/blood-2018-99-119642

Background: Relapse remains a serious event and main obstacle to permanent cure in childhood acute myeloid leukemia (AML). Reduction of measurable/minimal residual disease (MRD) assessed by real-time quantitative PCR (qPCR) during therapy is predicti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::353c0fd987a10286297c8b440ff07aca
https://pubmed.ncbi.nlm.nih.gov/32191348

Zobrazit plný text záznamu

Vybrat výsledek číslo 10 10

Treatment of Molecular Relapse by Cessation of Immunosuppression after Hematopoietic Stem Cell Transplantation in Pediatric FLT3 -ITD AML Monitored by WT1 Expression in Peripheral Blood

Autor: Marianne Ifversen, Maria Hansen, Charlotte Guldborg Nyvold, Kristian Løvvik Juul-Dam, Henrik Hasle

Publikováno v: Løvvik Juul-Dam, K, Ifversen, M, Guldborg Nyvold, C, Hansen, M & Hasle, H 2019, ' Treatment of Molecular Relapse by Cessation of Immunosuppression after Hematopoietic Stem Cell Transplantation in Pediatric FLT3-ITD AML Monitored by WT1 Expression in Peripheral Blood ', Journal of Pediatric Hematology/Oncology, vol. 41, no. 5, pp. 417–419 . https://doi.org/10.1097/MPH.0000000000001365
Løvvik Juul-Dam, K, Ifversen, M, Guldborg Nyvold, C, Hansen, M & Hasle, H 2019, ' Treatment of Molecular Relapse by Cessation ofImmunosuppression After Hematopoietic Stem CellTransplantation in Pediatric FLT3-ITD AML Monitored by WT1 Expression in Peripheral Blood ', Journal of Pediatric Hematology/Oncology, vol. 41, no. 5, pp. 417-419 . https://doi.org/10.1097/MPH.0000000000001365

Relapse after hematopoietic stem cell transplantation in pediatric acute myeloid leukemia is a fatal event in the majority of cases. Immunotherapy may prevent an impending relapse if instituted at first molecular evidence of disease recurrence. Wilms

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d69f3e0ae8e16c0c9b9a8d4a966893a3
https://portal.findresearcher.sdu.dk/da/publications/478fbbfd-9a49-42da-9341-7c16cd462608